Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 97

Results For "PAT"

6801 News Found

Remdesivir demand was exaggerated: Dr. Sharvil Patel
News | May 28, 2021

Remdesivir demand was exaggerated: Dr. Sharvil Patel

Dr. Sharvil Patel cites the example of prescriptions being handed over to patients despite unavailability of enough stock of such medicines


Cadila Healthcare posts consolidated PAT of Rs. 679 Cr
News | May 27, 2021

Cadila Healthcare posts consolidated PAT of Rs. 679 Cr

Cadila Healthcare has reported total income of Rs.15139.4 crores FY 2020-21


Strides Pharma Science posts consolidated PAT of Rs. 46.08 Cr in Q4FY21
News | May 27, 2021

Strides Pharma Science posts consolidated PAT of Rs. 46.08 Cr in Q4FY21

Strides Pharma Science reported total income of Rs.3367.29 crores during FY 2020-21


Alkem Q4FY21 consolidated PAT drops QoQ to Rs. 239.99 Cr
News | May 25, 2021

Alkem Q4FY21 consolidated PAT drops QoQ to Rs. 239.99 Cr

It posted net profit of Rs.188.77 crores for the period ended March 31, 2020.


Dr. Reddy's Laboratories see marginal dip in FY 2021 PAT
News | May 15, 2021

Dr. Reddy's Laboratories see marginal dip in FY 2021 PAT

Dr. Reddy's Laboratories has reported total income of Rs.19338.9 crores during FY ended March 31, 2021


Lupin reports Q4FY21 consolidated PAT of Rs. 460.36 Cr
News | May 13, 2021

Lupin reports Q4FY21 consolidated PAT of Rs. 460.36 Cr

It reported total income of Rs.15299.25 crores during the FY ended March 31, 2021


Zydus Wellness reports Rs. 133.13 Cr consolidated PAT in Q4FY21
News | May 10, 2021

Zydus Wellness reports Rs. 133.13 Cr consolidated PAT in Q4FY21

Glucon-D, Sugar Free, EverYuth Scrub, Peel Off Face Mask and Nycil maintained their leadership positions in-their respective categories as on March 2021.


RPG Life Sciences reports Rs. 6.92 crore PAT in Q4 FY2020-21
News | May 03, 2021

RPG Life Sciences reports Rs. 6.92 crore PAT in Q4 FY2020-21

The company reported total income of Rs.390.05 crores during the 12 months period ended March 31, 2021


Ajanta Pharma Q4FY21 consolidated PAT drops QoQ to Rs. 159.26 Cr
News | May 03, 2021

Ajanta Pharma Q4FY21 consolidated PAT drops QoQ to Rs. 159.26 Cr

The companyreported total income of Rs.2915.67 crores during the 12 months period ended March 31, 2021


DSM secures victory in patent infringement litigation against Anhui Tiger
News | March 02, 2021

DSM secures victory in patent infringement litigation against Anhui Tiger

Tiger can no longer make an important biotin intermediate using a DSM patented process.